2,4-二氧代-4-苯丁酸甲酯 | 20577-73-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2,4-二氧代-4-苯丁酸甲酯
• 中文别名: 2,4-二羰基苯丁酸甲酯
• 英文名称: methyl 4-phenyl-2,4-dioxobutanoate
• 英文别名: methyl 2,4-dioxo-4-phenylbutanoate；methyl benzoylpyruvate；benzoylpyruvic acid methyl ester
• CAS: 20577-73-5
• 化学式: C₁₁H₁₀O₄
• mdl: MFCD00225528
• 分子量: 206.198
• InChiKey: AQYAHPDSJAFBOS-UHFFFAOYSA-N

物化性质

• 熔点：
  59-60°C
• 沸点：
  335.6±25.0 °C(Predicted)
• 密度：
  1.205±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少许）、DMSO（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.181
• 拓扑面积：
  60.4
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2918300090
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  存于室温、干燥且密封的环境中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 2,4-dioxo-4-phenylbutanoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 2,4-dioxo-4-phenylbutanoate
CAS number: 20577-73-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H10O4
Molecular weight: 206.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2,4-二氧代-4-苯丁酸甲酯 在 lithium hydroxide monohydrate 作用下， 以 四氢呋喃 、 甲醇 、 水 为溶剂， 生成 2,4-二氧代-4-苯基-丁酸
  参考文献：
  名称：

  非肽类新型血小板聚集抑制剂：设计、合成、生物评价、SAR 和计算机研究

  摘要：

  一系列 2-oxo-2-phenylethylidene 连接的 2-oxo-benzo[1,4]oxazine 类似物 17a-x 和 18a-o，在环 A 和环 C，在更环保的条件下以优异的产率（高达 98%）合成。与标准参考阿司匹林 (IC50 = 21.34 ± 1.09 µg/mL) 相比，评估了这些类似物 17a-x 和 18a-o 的花生四烯酸 (AA) 诱导的血小板聚集抑制活性。在所有筛选的化合物中，与阿司匹林相比，8 种类似物 17i、17x、18f、18g、18h、18i、18l 和 18o 被鉴定为有前途的血小板聚集抑制剂。此外，通过 MTT 分析对 3T3 成纤维细胞系进行了有希望的化合物（17i、17x、18f-18i、18l、和 18o) 并且发现这些化合物在性质上是无毒的。此外，这些化合物（17i、17x、18f-18i、18l 和 18o）的 AA 诱导的血

  DOI：

  10.1002/ardp.201700349
• 作为产物：
  描述：

  2-methoxy-5-phenylfuran 在 rose bengal 氧气 作用下， 以 丙酮 为溶剂， 反应 1.5h， 生成 2,4-二氧代-4-苯丁酸甲酯
  参考文献：
  名称：

  Graziano, M. Liliana; Iesce, M. Rosaria; Cermola, Flavio, Journal of the Chemical Society. Perkin transactions I, 1991, # 6, p. 1479 - 1484

  摘要：

  DOI：

文献信息

• [EN] CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME<br/>[FR] COMPOSÉS DE SULFAMIDE CYCLIQUE ET LEURS PROCÉDÉS D'UTILISATION
  申请人：ASSEMBLY BIOSCIENCES INC

  公开号：WO2018160878A1

  公开（公告）日：2018-09-07

  The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful as modulators of Hepatitis B (HBV) core protein, and methods of treating Hepatitis B (HBV) infection.

  本公开提供了部分环磺胺化合物及其药物组合物，可用作乙型肝炎（HBV）核心蛋白的调节剂，并用于治疗乙型肝炎（HBV）感染的方法。
• Synthesis and Structure (Z)-N-Aryl-2-hydroxy-4-oxo-4-phenylbut-2-enamides
  作者：V. L. Gein、T. M. Zamaraeva、E. V. Gorgopina、N. M. Igidov、O. V. Bobrovskaya、M. V. Dmitriev

  DOI：10.1134/s1070363218040321

  日期：2018.4

  Reactions of 5-phenyl-2,3-dihydrofuran-2,3-dione with aromatic amines in anhydrous dioxane or methyl benzoylpyruvate with aromatic amines in the presence of sodium acetate in glacial acetic acid afforded (Z)-N-aryl-2-hydroxy-4-oxo-4-phenylbut-2-enamides.

  5-苯基-2,3-二氢呋喃-2,3-二酮与芳族胺在无水二恶烷中反应或苯甲酰基丙酮酸甲酯与芳族胺在乙酸钠存在下在冰醋酸中反应得到（Z）-N-芳基-2-羟基-4-氧代-4-苯基丁-2-烯酰胺。
• Synthesis and anticancer activity of heteroaromatic linked 4β-amido podophyllotoxins as apoptotic inducing agents
  作者：Ahmed Kamal、Jaki R. Tamboli、M.V.P.S. Vishnuvardhan、S.F. Adil、V. Lakshma Nayak、S. Ramakrishna

  DOI：10.1016/j.bmcl.2012.10.099

  日期：2013.1

  17a–i and 18a–d) were synthesized and evaluated for anticancer activity against five human cancer cell lines. Among the series, one of the compound 17g showed significant antiproliferative activity in A549 (lung cancer) cell line. Flow cytometric analysis showed that 17g arrested the cell cycle in the G2/M phase leading to caspase-3 dependent apoptotic cell death. Further, Hoechst 33258 staining and DNA

  合成了一系列不同的杂芳族连接的4β-酰胺基鬼臼毒素偶联物（16a – i，17a – i和18a – d），并评估了其对五种人类癌细胞系的抗癌活性。在该系列中，一种化合物17g在A549（肺癌）细胞系中显示出显着的抗增殖活性。流式细胞仪分析表明，17g细胞在G2 / M期停滞，导致caspase-3依赖性凋亡细胞死亡。此外，Hoechst 33258染色和DNA片段化分析还表明17g通过凋亡诱导细胞死亡。
• Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies
  作者：Jiqing Ye、Xiao Yang、Min Xu、Paul Kay-sheung Chan、Cong Ma

  DOI：10.1016/j.ejmech.2019.111635

  日期：2019.11

  strain. Moreover, the in silico ADME predictions showed that the selected compounds had comparable properties with oseltamivir carboxylate, which demonstrated the druggablity of these derivatives. Furthermore, molecular docking studies showed that the most potent compound 6f and 10i could adopt different modes of binding interaction with NA, which may provide novel solutions for treating oseltamivir-resistant

  新型有效的神经氨酸酶（NA）抑制剂的发现仍然是治疗由流感引起的传染病的有吸引力的方法。在这项研究中，我们描述了新型的N-取代的奥司他韦衍生物的设计和合成，以探测与NA的活性位有关的150腔。NA抑制研究表明，新衍生物显示出对临床流感病毒株NA的抑制活性，IC50值为nM。此外，计算机模拟ADME的预测结果表明，所选化合物与oseltamivir羧酸盐具有可比的特性，这证明了这些衍生物的药物相容性。此外，分子对接研究表明，最有效的化合物6f和10i可以采用与NA相互作用的不同模式，可能为治疗耐奥司他韦的流感提供新颖的解决方案。根据研究结果，我们认为化合物6f和10i作为新型抗病毒药物具有进一步研究的潜力。
• Anthranilamide-Pyrazolo[1,5-a]pyrimidine Conjugates as p53 Activators in Cervical Cancer Cells
  作者：Ahmed Kamal、Jaki R. Tamboli、M. Janaki Ramaiah、S. F. Adil、G. Koteswara Rao、A. Viswanath、Adla Mallareddy、S. N. C. V. L. Pushpavalli、Manika Pal-Bhadra

  DOI：10.1002/cmdc.201200205

  日期：2012.8

  arrest in HeLa cells and G1 cell‐cycle arrest in SiHa cells. Immunocytochemistry assays revealed that these compounds cause nuclear translocation of p53, thereby indicating the activation of p53. In cervical cancer cells, the p53 protein is degraded by E6 oncoprotein. Immunoblot and RT‐PCR analyses proved the presence of mitochondria‐mediated apoptosis with involvement p53 target genes such as BAX,

  设计，合成了新的蒽酰胺-吡唑并[1,5- a ]嘧啶共轭物库，并评估了它们对宫颈癌细胞如HeLa和SiHa的抗癌活性，这些细胞的p53含量很低。所有24种结合物均显示出抗增殖活性，其中一些显示出明显的细胞毒性。在与细胞周期分布相关的测定中，这些结合物诱导HeLa细胞和G 1中的G 2 / M阻滞SiHa细胞中的细胞周期停滞。免疫细胞化学测定显示这些化合物引起p53的核易位，从而表明p53的激活。在子宫颈癌细胞中，p53蛋白被E6癌蛋白降解。免疫印迹和RT-PCR分析证明存在线粒体介导的细胞凋亡，其中涉及p53靶基因，例如BAX，Bcl2和p21（CDKI）。而且，这些化合物增加了p53的磷酸化形式，并提供了诱导细胞凋亡的信号。有趣的是，其中一种缀合物是（2-苯基-7-（3,4,5-三甲氧基苯基）吡唑并[1,5 - a ]嘧啶-5-基）（4-（2-（噻吩-2-基甲基氨基）苯甲酰基）哌嗪-1-